Ophthalmologists from Columbia and Weill Cornell Medicine hold a position of prominence in the field, having made great strides in the diagnosis and treatment of eye conditions through development and application of retinal surgery techniques, laser procedures, and therapies for age-related eye disease.
New Report: In Our DNA
Read the full report to dive deeper into how Precision Ophthalmology™ is reshaping the future of eye care.
Ophthalmology
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
